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Abstract: Hodgkin’s disease (HD) has unique epidemiological features with diversified pathologies. The aim of 
this study was to investigate the clinicopathological pattern of HD at King Abdulaziz University Hospital 
(KAUH), Jeddah. Our results will be compared to those in the literatures. In addition, the relationship between 
peripheral blood lymphopenia on presentation, and clinical and laboratory variables among HD patients will also 
be addressed. A total of 81 HD patients were included in this study. The records were analyzed retrospectively 
from January 1998 through December 2004 and recorded in a structured form. In order to determine the 
importance of lymphopenia on presentation as a diagnostic marker in HD a comparison was made to a similar 
number of patients with non-Hodgkin’s lymphoma (NHL) after standardization for age, sex and clinical 
presentation. Moreover, the association between lymphopenia and clinical and laboratory variables were also 
studied. There were 54 (66.7%) non-Saudi and 27 (33.3%) Saudi patients with a male to female ratio of 1.3:1.  
The mean age of the patients was 40.4 years, ranging from (12-82) years with a SD of r18.95. Cervical lymph 
nodes were the most common finding at the time of presentation.  Mixed cellularity was the most frequent 
pathology followed by nodular sclerosis with prevalence of advanced stages of the disease in 48 (59.2%) and B 
symptoms 67 (82.7%).  Lymphopenia was seen in 33 patients, 24 (72.7%) of them were above the age of 30. A 
comparison between Hodgkin’s disease and non-Hodgkin’s lymphoma regarding lymphopenia, using the same 
number of patients after standardization for age, sex and presentation did not turn out to be significant (P > 0.05). 
Relationship between lymphopenia and other clinical and laboratory variables also did not turn out to be 
significant with the exception of anemia where the P-value was <0.05. Our data demonstrated that HD is more 
common among males, mainly at middle age with lack of bimodal age distribution. Cervical lymphadenopathy is 
a common presenting sign. Similar to other developing countries the mixed cellularity type of HD was the most 
common type followed by the nodular sclerosis type. Lymphopenia on presentation is common among patients 
with HD especially above the age of 30. In order to analyze the importance of this finding as a diagnostic marker 
in HD, a comparison was made to NHL patients but the association was insignificant. The relationship between 
lymphopenia and anemia among HD patients is significant as compared to other clinical and laboratory variables.
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Introduction
Hodgkin’s disease (HD) is a relatively rare malignancy which was initially described by 
Thomas Hodgkin in 1832[1].  It occurs in males more commonly than females (sex ratio 
approximately 1.4:1).  It has a bimodal age distribution demonstrated in industrialized 
populations with one peak in the 20’s and a second peak over the age of 50.  In the developing 
countries, the young adult peak is not seen, and instead a higher incidence of HD is seen among 
children less than 15 years of age [2]. There are important observations that correlate socio-
economic factors and disease incidence [3].  Reports of clustering of cases in a single household 
are frequent. Urban people with higher education seem to be more affected with the disease than 
others [4].  
Although the etiology of HD is unknown, epidemiologic data suggest that viral factors, 
especially Epstein-Barr virus (EBV) may play a causal role [5].  The diagnosis of HD depends on 
the finding of multinucleated Reed-Sternberg (RS) cells or their variants in an inflammatory 
background of benign reactive cells consisting of lymphocytes, histiocytes, neutrophils, plasma 
cells and fibroblasts [6]. 
The disease has been classified using the Rye classification system into four pathological 
subtypes (nodular sclerosis, mixed cellularity, lymphocyte predominance and lymphocyte 
depleted).  The most common subtype in western countries is nodular sclerosis but in Asia it is 
mixed cellularity [7]. The Ann Arbor staging system was adopted and generally accepted [8].  It is 
a four-staged disease (I, II, III, and IV) which is very crucial for analyzing the clinical and 
epidemiological behaviour of the disease. The presence of fever in excess of 38oC, drenching 
night sweats and weight loss exceeding 10 percent of baseline body weight during the 6 months 
preceding diagnosis are designated as having “B” symptoms.  Recent reports from the National 
Cancer Registry have indicated that HD accounted for 3.8% of all 5,616 newly diagnosed cancer 
cases. It ranked eight for males and 12th for females [9].
The aim of this study was to investigate the clinicopathologic pattern of HD at King 
Abdulaziz University Hospital (KAUH), Jeddah, and to compare the results with those 
documented in the literatures. Moreover, the relationship, if any, between peripheral blood 
lymphopenia on presentation, clinical and laboratory variables will be also addressed.
Subjects and Methods
A total of 81 adult patients with HD diagnosed at KAUH between January 1998 and 
December 2004 were studied retrospectively.  Medical records of all patients were reviewed, 
and clinical and pathological informations were recorded in a structured form.  In order to apply 
Ann Arbor staging system properly, all informations were reviewed carefully including the main 
presenting complaints, physical examination, laboratory work, radiological assessment, 
histology reports, bone marrow aspiration and biopsy findings if available.  Lymph node or 
tissue biopsy specimens were reviewed again, to be certain that they are qualified for the 
histologic subtypes.  Immunohistochemical staining was performed using a panel of antibodies 
against CD15, CD30, and (CD20 and CD79a) for lymphocyte predominant histologic subtype. 
Lymphocyte count of cases with non-Hodgkin's lymphoma, were collected and 33 patients with 
lymphopenia were compared to those with similar finding in NHL after standardization for age, 
sex and clinical presentation.
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The clinical and laboratory data were processed using statistical program “SPSS-V10”. 
To obtain descriptive statistics (number and percent), analytical statistics (cross tabulation and 
Chi-square) were applied. P-value was considered significant at <0.05. Data were graphically 
represented using graphic program. All cases of HD were classified using the Rye classification 
system into four pathological subtypes (lymphocyte predominant, nodular sclerosis, mixed 
cellularity and lymphocyte depleted) [7].
Results
Among the 81 HD patients, 54 (66.7%) were Non-Saudi and 27 (33.3%) were Saudi.  
There were 46 (56.8%) men and 35 (43.2%) women with a male to female ratio 1.31:1.  The 
mean age of the patients was 40.4 years, ranging (12-82) years, with a SD of r18.95.  The most 
common location of HD at the time of diagnosis was the cervical lymph nodes, 53 cases (65.9%) 
followed by mediastinal and abdominal lymph nodes 6 (7.3%) cases each while axillary lymph 
nodes were found in 3 (3.7%) patients.  Only one case had primary extranodal presentation with 
lung involvement.  Interestingly, 11 patients (13.6%) presented with B symptoms with no 
palpable lymph nodes. Thirty-three patients (40.7%) had histologic features of mixed cellularity, 
whereas nodular sclerosis was the next most frequent histologic subtype seen in thirty one 
patients (38.3%) followed by lymphocyte predominant in thirteen patients (16.1%), while only 3 
(4.9%) patients had lymphocyte depleted histologic subtypes.  Eight patients (9.9%) had Stage I 
HL disease; 25 (30.9%) stage II, 27 (33.3%)  Stage III and 21 (25.9%) had Stage IV. Advanced 
stages were seen predominantly with mixed cellularity 22 (66.7%) and lymphocyte depleted 
histology subtypes 4 (100%) (Figure1). Sixty-seven (82.7%) patients were reported with B 
symptoms (fever, night sweats and weight loss). 
                               Figuer 1: Relationship between different histologic subtypes and stages of Hodgkin's disease
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The frequency of B symptoms was highest in mixed cellularity and lymphocyte depleted
histologic subtypes 28 (84.8%) respectively. Out of 77 available bone marrow specimens of HD 
cases, evidence of involvement was seen only in 11 (14.3%). The relationship between different 
histologic subtypes and bone marrow involvement is shown in (figure 2) which demonstrates 
that all the four cases of lymphocyte depleted histologic subtypes revealed the bone marrow
involvement. Figure 3 summarizes the association between different histologic subtypes and 
outcome which remained inconclusive. Characteristic feature of patients with HD are 
summarized in table 1. 
Table 1:  Characteristic features of patients with Hodgkin’s disease
Chracteristic No %
Age
 30 y
t 30 y
28
53
34.6
65.4
Sex
Males
Females
46
35
56.8
43.2
Race
Saudi
Non-Saudi
27
54
33.3
66.7
Presenting Lymph
nodes:
Neck/Multiple
Axillary
Mediastinal
Inguinal
Abdominal
Extralymphatic
B-symptoms
53
3
6
1
6
1
11
65.4
3.7
7.4
1.2
7.4
1.2
13.6
Histologic subtypes
Lympho. pred.
Nod. sclerosis
Mixed cell
Lympho. dep.
13
31
33
4
16.1
38.3
40.7
4.9
Stage
I
II
III
IV
8
25
27
21
9.9
30.9
33.3
25.9
B symptoms*
Positive
Negative
67
14
82.7
17.3
Bone marrow
Not involved
Involved 6611
85.7
14.3
     * fever, night sweats & weight loss 
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Figure 2: Relationship between different hitologic subtypes and bone marrow involvement
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Figure 3: Relationship between different histologic subtypes and bone marrow
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Lymphopenia was observed in 72.7% patients with HD older than 30 years. The 
relationship between peripheral blood lymphopenia on presentation seen in 33 patients with HD, 
age, sex race, stages of the disease, histologic subtypes, B symptoms, Hb, LDH, uric acid and 
finally outcome were studied (Table 2), and the findings were not significant with the exception 
of anemia which showed striking association with lymphopenia  (P value <0.05). To study the 
significance of lymphopenia as a diagnostic marker in HD, a comparison was made using 
similar number of cases of non-Hodgkin’s lymphoma (NHL) after standardization for age, sex 
and presentation. The P value was >0.05.
   Table 2: Relationship between low lymphocyte count with clinical and laboratory variables in Hodgkin’s disease
High
Lymphocyte
Low
Lymphocyte
Statistical
AnalysisCharacteristic Features
No (%) No (%) Chi-square P-value
Age (years): (n=70)
<30
>30
14
23
37.8
62.2
9
24
27.3
72.7
0.46 >0.05
Sex: (n=70)
Males
Females
23
14
62.2
37.8
16
17
48.5
51.5
0.83 >0.05
Race: (n=70)
Saudi
Non-Saudi
15
22
40.5
59.5
9
24
27.3
72.7
0.83 >0.05
Stage of the disease
(n=70)
I and II
III and IV
18
19
48.6
51.4
9
24
27.3
72.7 2.50 >0.05
Histopath- subtypes
(n=70)
Lymphocyte pred
Nodular sclerosis
Mixed cellularity
Lymphocyte dep.
6
14
16
1
16.2
37.8
43.3
2.7
6
9
15
3
18.2
27.3
45.4
9.1
0.01
0.47
0.00
0.40
>0.05
>0.05
>0.05
>0.05
B-symptoms: (n=70)
Positive
Negative
29
8
78.4
21.6
31
2
93.9
6.1
2.29 >0.05
Hb level:  (n=70)
Low
Normal
17
17
50
50
25
5
83.3
6.7
0.014 <0.05
LDH: (n=60)
Normal
High
8
23
25.8
74.2
4
25
13.8
86.2
0.71 >0.05
Uric acid: (n=53)
Normal 
High
23
5
82.1
17.9
22
3
88.0
12.0
0.04 >0.05
Outcome: (n=57)
Cured or remission
Relapse
Died
21
10
0
67.7
32.3
0
12
11
3
46.2
42.3
11.5
5.1 >0.05
Disscusion
In our study we reported an excess of non-Saudi patients (66.7%) because KAUH is 
considered as a referral center in the Western region of Saudi Arabia with admission facilities of 
non-Saudi patients, males were affected more than females with male to female ratio of 1.3:1 
which is lower than what has been reported earlier from Kingdom of Saudi Arabia [10, 11] and 
many other developing countries [12, 13] but is close to ratio reported from the West [14]. 
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In economically developed countries of the West, HD is reported with a bimodal age 
distribution with an early peak appearing in young adulthood and another peak after the age of 
50 years. Our results didn’t show an increasing incidence of HD in young adults but it did show
increasing frequency with advancing age, 53 cases (64.5%). Unlike similar studies from Oman, 
Bahrain and North Jordan which suggested a regional peak occurrence in childhood with highest
frequencies occurring in first and second decade of life[13,15,16]. This may indicate that the 
patterns of HD are changing not only in the developed countries but also in the developing 
countries[11] or might be  a result of lack of discrimination between HD and NHL, because some 
patients may fall in the category of diffuse large B-cell lymphoma after re-characterization.
HD presents as cervical lymphadenopathy in 60-80% of the cases, our data revealed that 
neck lymphadenopathy was the most common presenting location at the time of diagnosis 
(65.4%) while primary extranodal involvement was very rare seen in (1.2%), which is similar to 
a previous study from United Arab Emirates[17]. B symptoms were found in approximately 25 
percent of patients. These symptoms were more common, occurring in up to 50 percent of cases, 
in more advanced disease [18].  We observed the prevalence of B symptoms in HD patients to be 
82.7 percent, in addition 11 (13.6%) patients presented initially with B symptoms with no 
palpable lymphadenopathy which suggest the importance of B symptoms as presenting signs [11].
The most frequently diagnosed entity was mixed cellularity histologic subtype (40.7%) 
followed by nodular sclerosis (38.3%). The results are in agreement with previous studies from 
Oman [13], Bahrain [15], Kuwait [19], KSA [20], Greece [21] and Turkey [22]. This pattern is different to 
what is seen in Western countries where the nodular sclerosis type of HD is the most common 
type, followed by mixed cellularity [23, 24]. Thirteen out of 33 mixed cellularity histologic subtype 
were above the age of 60 years with male prevalence. This discrepancy however, could have 
been the result of small sample group in our study. The lymphocyte depleted type of HD 
comprised 4.9% of HD cases, which is higher than neighboring countries [15, 16, 24]. Lymphocyte 
predominant type, which is now considered as a distinct entity of HD according to the recent 
WHO classification system of lymphoma [24], accounted for 16% of all HD cases. This figure is 
higher than the 2-5% figure reported in the West [24] and the 4-8.3% figure from neighboring 
countries [15, 25, 26]. We observed the prevalence of advanced stages of the disease (stage III, IV) 
in 48 (59.2%) which is similar to a previous study from the Kingdom of Saudi Arabia [11]. 
However, this presentation is comparatively less than a frequency range of 65-95% reported 
earlier from Kingdom of Saudi Arabia and other developing countries [20, 27, 28]. 
Lower incidence of advanced clinical stages might result from early diagnosis because of 
comprehensive clinical work-up and advanced imaging studies. Bone marrow involvement in 
HD can only be rarely demonstrated by the trephine biopsy. Bone marrow study is not indicated 
in the case of females with clinical stage I-II; a disease which carries extremely low incidence of 
bone marrow involvement [29]. In our study, bone marrow infiltration was seen in only 11
(14.3%) cases.
No conclusion can be drawn from the results of treatment outcome of HD in relation to 
different histologic subtypes because of the small sampling in our study and the fact that some 
of the patients lost follow-up or still not considered as cured. Patients with HD are known to 
have peripheral blood lymphopenia [30]. The prognostic significance of this observation and its 
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implication on immune system remain controversial[30] . Nevertheless, peripheral blood 
lymphopenia was included in the international prognostic factors project on advanced HD as an 
important prognostic variable [31] . Lymphopenia was observed in 33 patients with HD, 24 
(72.7%) of them were older than of 30 years. To determine its significance as a diagnostic 
marker in HD, we carried out a comparison to similar number of patients with non-Hodgkin’s 
lymphoma. There was no significant difference between the two groups of haematologic
malignancies (P value >0.05). Moreover, the relationship between peripheral blood lymphopenia 
in HD on presentation, clinical and laboratory variables which included age, sex, race, clinical 
stages, histologic subtypes, B symptoms, LDH, uric acid and finally outcome were not 
significant. 
Anemia in HD is mainly normocytic-normochromic type, rarely it can be Coomb’s 
positive autoimmune hemolytic in nature. The international prognostic factors project on 
advanced HD developed a seven-factor prognostic score, lymphopenia and anaemia were among 
them[31]. The relationship between normocytic normochromic anaemia and lymphopenia in HD 
in our cohort turned out to be significant (P<0.05). The reason for that is probably because both 
are seen in advanced stages of the disease but this finding needs to be consolidated by larger 
study.
A notable feature in this study is a male predominance and there is no bimodal 
distribution of age in our hospital. Most patients present initially with cervical 
lymphadenopathy. Mixed cellularity is the most frequent histological subtype followed by 
nodular sclerosis, constitutional symptoms are reported in most of the cases. Almost two third of 
the cases were advanced. Lymphopenia on presentation was observed frequently above the age 
of 30, but it did not turn out to be a significant diagnostic marker in HD when compared to non-
Hodgkin’s lymphoma. The relationship between lymphopenia in HD and age, sex, race, clinical 
stage, histopathologic subtypes, B symptoms, LDH, uric acid and finally outcome did not turn 
out to be significant. A significant association is reported between lymphopenia and anemia, 
probably because both are reported in advanced clinical stages of the disease.
The data presented here is an approximate assessment of the epidemiological features of 
HD at KAUH.  Further studies together with national cancer registry data will probably identify
epidemiology and risk factors for HD which is needed to make definite preventive and 
therapeutic measures.  Moreover numerous reports have suggested a strong association between 
EBV infection and the development of HD. It will be interesting to conduct future study to 
assess this relationship in our hospital population using the new WHO classification.
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